2
Trustees’ Annual Report for the period
From 01/01/2025 Period start date To 31/12/2025 Period end date
Charity name: NTM NETWORK UK
Charity registration number: 1207531
Objectives and Activities
| Objectves and Actvites | ||
|---|---|---|
| SORP reference |
||
| Summary of the purposes of the charity as set out in its governing document |
Para 1.17 | NTM Network UK was established in December 2014 in response to the need for improved management of the rising number of NTM isolates identfed in clinical practce. It provides a framework within which NTM infectons and disease can be systematcally investgated, researched and managed. NTM Network UK aims to: Consolidate the mult-disciplinary expertse available to develop standardised, cost-efectve methods and tools to identfy NTM, and to improve NTM infecton and disease diagnosis and management. Standardise clinical practce and data collecton, including clinical assessments, microbiology, immunology, radiology, health status/quality of life scores and outcomes. Develop protocols for data collecton, clinical sampling, and sample storage (to include sputum, blood, laboratory and imaging data). Obtain mult-centre ethical approval to enable data collecton and long-term projects to take place. Develop a harmonised database of NTM patents for clinical use and research analysis. Evaluate the process and outputs of the research actvites. Support new areas of research, actvites and events proposed by members. Assess and support the development of collaboratons and interactons within NTM Network UK, and with other research organisatons and clinical groupings. Work to make public health surveillance of NTM more robust. Assist with resolving strategic level local and regional issues and risks. |
| Support the UK patent associaton, NTM Patent Care UK, in achieving its charitable aims. Support and provide educatonal actvites in the feld of NTM. |
||
|---|---|---|
| Summary of the main actvites in relaton to those purposes for the public beneft, in partcular, the actvites, projects or services identfed in the accounts. |
Para 1.17 and 1.19 |
Main actvites for this reportng period include the following: a) NTM Network UK has held Quarterly Members Meetngs to update members on Network actvites, share reports from specialist interest groups, and hear presentatons from invited guest speakers. These meetngs promote collaboraton, educaton, and knowledge sharing among healthcare professionals involved in the care of people with NTM disease. b) NTM Network UK has held Management Group Meetngs every 6 months to review progress, oversee ongoing projects, and plan future actvites in line with the charity’s strategic objectves. c) NTM Network UK held an Annual Meetng (23/10/2025) during which Network membership, output and funding were all reviewed and objectves were set for the year ahead d) NTM Network UK has produced The Patent’s Guide to NTM Standards of Care in conjuncton with NTM Patent Care UK e) NTM Network UK supported NTM research by submitng a manuscript for publicaton (under review) on a Natonal Audit of Clinical Practce f) The Pharmacy Interest Group fnalised and published the NTM Monographs (htps://www.ntmnetworkuk.com/ntm- drug-monographs ) g) The Extrapulmonary NTM (EPNTM) Interest Group has initated a Natonal Clinical Advice Service for EPNTM h) The Nursing Interest Group has held regular educatonal sessions to discuss complex cases as well as providing advice and peer support i) Across these actvites, NTM Network UK has aimed to improve outcomes for people with NTM disease in the UK, by strengthening collaboraton between healthcare professionals, promotng consistency and quality in clinical care, and supportng educaton and research. |
| Statement confrming whether the trustees have had regard to the guidance issued by the Charity Commission on public beneft |
Para 1.18 | The trustees have had regard to the Charity Commission’s guidance on public beneft. |
|---|---|---|
Additional information (optional)
You may choose to include further statements where relevant about:
| SORP reference |
||
|---|---|---|
| Policy on grant making |
Para 1.38 | N/A |
| Policy on social investment including program related investment |
Para 1.38 | N/A |
| Contributon made by volunteers |
Para 1.38 | All actvites undertaken by NTM Network UK during the reportng period were delivered through the work of volunteers. The Network’s members, including clinicians, pharmacists, scientsts, and other healthcare professionals, contributed their tme and expertse for free in developing the materials produced by NTM Network UK. The charity’s ability to deliver these outputs relies entrely on the ongoing commitment and goodwill of its volunteer members. |
| Other | N/A |
Achievements and Performance
| SORP reference |
||
|---|---|---|
| Summary of the main achievements of the charity, identfying the diference the charity’s work has made to the circumstances of its benefciaries and any wider benefts to society as a whole. |
Para 1.20 | Main achievements for this reportng period include the following: a) NTM Network UK has produced The Patent’s Guide to NTM Standards of Care in conjuncton with NTM Patent Care UK b) NTM Network UK has developed patent and clinician checklists covering new diagnosis and outpatent management c) Development of scientfc abstracts to share fndings with the wider healthcare community, including analysis of the use of bedaquiline in NTM treatment |
- d) Publication of detailed NTM Monographs by the Pharmacy Interest Group, offering practical guidance for clinicians and pharmacists in the effective use of NTM treatments (htps://www.ntmnetworkuk.com/ntm-drugmonographs).
Additional information (optional)
You may choose to include further statements where relevant about:
| Achievements against objectves set | Para 1.41 | N/A |
|---|---|---|
| Performance of fundraising actvites against objectves set | Para 1.41 | N/A |
| Investment performance against objectves | Para 1.41 | N/A |
| Other | N/A |
Financial Review
| Review of the charity’s fnancial positon at the end of the period |
Para 1.21 |
The charity is in positve balance. The charity did not carry forward any income or expenses from theprevious NTM Network UK actvites |
|---|---|---|
| Statement explaining the policy for holding reserves statng why they are held |
Para 1.22 |
The Charity has no policy for holding reserves and a policy is not considered necessary at this tme as the charity contnued to require limited spending during this reportng period. |
| Amount of reserves held | Para 1.22 |
NA |
| Reasons for holding zero reserves |
Para 1.22 |
The charity has had very limited spending over the reportng period, so reserves are not considered necessary. |
| Details of fund materially in defcit |
Para 1.24 |
N/A |
| Explanaton of any uncertaintes about the charity contnuingas agoingconcern |
Para 1.23 |
N/A |
Additional information (optional)
You may choose to include further statements where relevant about:
| The charity’s principal sources of funds (includingany |
Para 1.47 |
The charity had a positve balance of £15,581.34 at the end of this period. Income had been received via fundraising undertaken by members of the NTM Network undertakingsponsored events. We |
|---|---|---|
| fundraising) | received £4500 from the pharmaceutcal company Shionogi B.V in support of our Annual Meetng which enabled us to invite world- leading experts in NTM to partcipate in a panel discussion |
|
|---|---|---|
| Investment policy and objectves including any social investment policyadopted |
Para 1.46 |
N/A |
| A descripton of the principal risks facing the charity |
Para 1.46 |
N/A |
| Other | N/A |
Structure, Governance and Management
| Structure, Governance and Management | ||
|---|---|---|
| Descripton of charity’s trusts: | N/A | |
| Type of governing document (trust deed, royal charter) |
Para 1.25 |
Consttuton of the Charitable Incorporated Organisaton (CIO) |
| How is the charity consttuted? (e.g unincorporated associaton, CIO) |
Para 1.25 |
Charitable Incorporated Organisaton (CIO) |
| Trustee selecton methods including details of any consttutonal provisions e.g. electon to post or name of any person or body enttled to appoint one or more trustees |
Para 1.25 |
Trustees include founding individuals and healthcare professionals, to ensure the best representaton of professionals in NTM care. |
Additional information (optional)
You may choose to include further statements where relevant about:
| Additonal informaton (optonal) You maychoose to include further statements where relevant about: |
||
|---|---|---|
| Policies and procedures adopted for the inducton and training of trustees | Para 1.51 |
N/A |
| The charity’s organisatonal structure and any wider network with which the charity works |
Para 1.51 |
N/A |
| Relatonship with any related partes | Para 1.51 |
N/A |
| Other | N/A |
Reference and Administrative details
| Charityname | NTM Network UK |
|---|---|
| Other name the charity uses |
N/A |
| Registered charity number Charity’s principal address |
1207531 |
|---|---|
| Royal Free London NHS Foundaton Trust, Pond St, Hampstead, London NW3 2QG |
Names of the charity trustees who manage the charity during period of report
| Trustee Name | Ofce (if any) | Dates acted if not for whole year |
Name of person (or body) enttled to appoint trustee (if any) |
|---|---|---|---|
| Marc Lipman | Trustee | ||
| Ronan Breen | Trustee | ||
| Ibrahim Abubakar | Trustee | ||
| Jennie Keane | Trustee | ||
| Lisa Morrison | Trustee |
Corporate trustees – names of the directors at the date the report was approved
Director name N/A
Name of trustees holding title to property belonging to the charity
| Trustee name N/A |
Dates acted if not for wholeyear | |
|---|---|---|
Funds held as custodian trustees on behalf of others
| Descripton of the assets held in this capacity Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregaton of such assets from the charity’s own assets |
N/A |
|---|---|
| N/A | |
| N/A |
Additional information (optional)
Names and addresses of advisers (Optional information)
| onal informaton (optonal) Names and addresses of advisers (Optonal informaton) |
onal informaton (optonal) Names and addresses of advisers (Optonal informaton) |
|---|---|
| Type of adviser Name Address |
|
| Type of adviser Name Address |
|
| N/A |
Name of chief executive or names of senior staff members (Optional information) N/A
Exemptions from disclosure
Reason for non-disclosure of key personnel details
N/A
Other optional information N/A
Declarations
The trustees declare that they have approved the trustees’ report above.
Signed on behalf of the charity’s trustees
Signature(s) Full name(s) Ronan Angus MacCormick Breen Position (eg Secretary, Chair, etc) Vice-Chair Date 31/10/2026